Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88291857 |
LAW OFFICE ASSIGNED |
LAW OFFICE 110 |
MARK SECTION |
MARK |
http://uspto.report/TM/88291857/mark.png |
LITERAL ELEMENT |
ECL COMMAND CENTER |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font style, size or color. |
EVIDENCE SECTION |
EVIDENCE FILE NAME(S) |
ORIGINAL PDF FILE |
evi_172823280-20191029231536293653_._ELC14_ECL_COMMAND_CENTER_Response_10292019.pdf |
CONVERTED PDF FILE(S)
(6 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\882\918\88291857\xml4\ROA0002.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\918\88291857\xml4\ROA0003.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\918\88291857\xml4\ROA0004.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\918\88291857\xml4\ROA0005.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\918\88291857\xml4\ROA0006.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\918\88291857\xml4\ROA0007.JPG |
DESCRIPTION OF EVIDENCE FILE |
Arguments in response to Office Action. |
GOODS AND/OR SERVICES SECTION (current) |
INTERNATIONAL CLASS |
042 |
DESCRIPTION |
Monitoring medical laboratory services; monitoring scientific laboratory services; monitoring laboratory experiments conducted on
behalf of others; software as a service featuring software for monitoring laboratory experiments and environment data; monitoring of scientific testing of chemicals, pharmaceuticals, biologics,
vaccines, and medical devices; biopharmaceutical research and scientific testing services; monitoring product safety and quality assurance testing for pharmaceuticals, biopharmaceuticals, chemicals,
medical devices, vaccines, and biologics; monitoring toxicological safety testing services for pharmaceuticals, chemicals, and consumer products |
FILING BASIS |
Section 1(a) |
FIRST USE ANYWHERE DATE |
At least as early as 07/19/2017 |
FIRST USE IN COMMERCE DATE |
At least as early as 07/19/2017 |
GOODS AND/OR SERVICES SECTION (proposed) |
INTERNATIONAL CLASS |
042 |
TRACKED TEXT DESCRIPTION |
Monitoring medical laboratory services; Medical laboratory
services; monitoring scientific laboratory services; scientific laboratory services; monitoring laboratory experiments conducted on behalf of others; conducting laboratory experiments remotely; software as a service featuring software for monitoring laboratory experiments and environment data; software as a service featuring software for
designing laboratory experiments, for running laboratory experiments, for analyzing laboratory experiment controls, equipment, and environment data, and for analyzing laboratory experiment
results; monitoring of scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; remote
scientific testing services of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; biopharmaceutical research and scientific testing
services; biopharmaceutical research design and scientific testing services; monitoring product safety and quality
assurance testing for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; product safety and quality
assurance testing services for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; monitoring toxicological safety
testing services for pharmaceuticals, chemicals, and consumer products; toxicological safety and quality assurance testing services for pharmaceuticals,
chemicals, and consumer products; software as a service for developing, executing, monitoring, and managing enterprise resource planning, experimental
logistics, manufacturing execution systems, and connected factories; software as a service featuring software for running computer simulations of
laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for
comparison of computer simulations against empirically observed laboratory experiment results; software as a service for providing regulatory compliance
documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; software as a service for processing of un-structured, semi-structured, and structured information relating to laboratory experiments and computer simulations of laboratory
experiments and biological and chemical phenomena and systems. |
FINAL DESCRIPTION |
Medical laboratory services; scientific laboratory services; conducting laboratory experiments remotely; software as a service
featuring software for designing laboratory experiments, for running laboratory experiments, for analyzing laboratory experiment controls, equipment, and environment data, and for analyzing
laboratory experiment results; remote scientific testing services of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; biopharmaceutical research design and scientific testing
services; product safety and quality assurance testing services for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; toxicological safety and quality
assurance testing services for pharmaceuticals, chemicals, and consumer products; software as a service for developing, executing, monitoring, and managing enterprise resource planning,
experimental logistics, manufacturing execution systems, and connected factories; software as a service featuring software for running computer simulations of laboratory
experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of
computer simulations against empirically observed laboratory experiment results; software as a service for providing regulatory compliance documentation following experiments, for performing
regulatory agencies audits following experiments, and for performing internal audits following experiments; software as a service for processing of un-structured, semi-structured, and structured
information relating to laboratory experiments and computer simulations of laboratory experiments and biological and chemical phenomena and systems. |
FILING BASIS |
Section 1(a) |
FIRST USE ANYWHERE DATE |
At least as early as 07/19/2017 |
FIRST USE IN COMMERCE DATE |
At least as early as 07/19/2017 |
ATTORNEY SECTION (current) |
NAME |
Paul K. Tomita |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
STANIFORD TOMITA LLP |
STREET |
PO BOX 591838 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94159 |
COUNTRY |
US |
PHONE |
415-305-8948 |
EMAIL |
paul@st-ip.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ECL.14 |
ATTORNEY SECTION (proposed) |
NAME |
Paul K. Tomita |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
STANIFORD TOMITA LLP |
STREET |
PO BOX 591838 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94159 |
COUNTRY |
United States |
PHONE |
415-305-8948 |
EMAIL |
paul@st-ip.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ECL.14 |
CORRESPONDENCE SECTION (current) |
NAME |
PAUL K. TOMITA |
FIRM NAME |
STANIFORD TOMITA LLP |
STREET |
PO BOX 591838 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94159 |
COUNTRY |
US |
PHONE |
415-305-8948 |
EMAIL |
paul@st-ip.com; ptomita@gmail.com; lana@st-ip.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ECL.14 |
CORRESPONDENCE SECTION (proposed) |
NAME |
Paul K. Tomita |
FIRM NAME |
STANIFORD TOMITA LLP |
STREET |
PO BOX 591838 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94159 |
COUNTRY |
United States |
PHONE |
415-305-8948 |
EMAIL |
paul@st-ip.com; ptomita@gmail.com; lana@st-ip.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ECL.14 |
SIGNATURE SECTION |
RESPONSE SIGNATURE |
/Paul K. Tomita/ |
SIGNATORY'S NAME |
Paul K. Tomita |
SIGNATORY'S POSITION |
Attorney of Record, CA bar member |
SIGNATORY'S PHONE NUMBER |
4153058948 |
DATE SIGNED |
10/29/2019 |
AUTHORIZED SIGNATORY |
YES |
FILING INFORMATION SECTION |
SUBMIT DATE |
Tue Oct 29 23:19:51 EDT 2019 |
TEAS STAMP |
USPTO/ROA-XXX.X.XXX.XX-20
191029231951363174-882918
57-700e21b307f345af65ea47
1d89186e989a6beeccb51b46f
dc850c2e385abb9f34e-N/A-N
/A-20191029231536293653 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
To the Commissioner for Trademarks:
Application serial no.
88291857 ECL COMMAND CENTER(Standard Characters, see http://uspto.report/TM/88291857/mark.png) has been amended as follows:
EVIDENCE
Evidence in the nature of Arguments in response to Office Action. has been attached.
Original PDF file:
evi_172823280-20191029231536293653_._ELC14_ECL_COMMAND_CENTER_Response_10292019.pdf
Converted PDF file(s) ( 6 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 042 for Monitoring medical laboratory services; monitoring scientific laboratory services; monitoring laboratory experiments conducted on behalf of others; software as a service
featuring software for monitoring laboratory experiments and environment data; monitoring of scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices;
biopharmaceutical research and scientific testing services; monitoring product safety and quality assurance testing for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and
biologics; monitoring toxicological safety testing services for pharmaceuticals, chemicals, and consumer products
Original Filing Basis:
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with
the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 07/19/2017 and first used in commerce at least as early as 07/19/2017 , and
is now in use in such commerce.
Proposed:
Tracked Text Description: Monitoring medical laboratory services;
Medical laboratory services;
monitoring scientific laboratory services;
scientific laboratory services;
monitoring laboratory experiments
conducted on behalf of others;
conducting laboratory experiments remotely;
software as a service featuring software for
monitoring laboratory experiments and environment data;
software as a service featuring software for designing laboratory experiments, for running laboratory
experiments, for analyzing laboratory experiment controls, equipment, and environment data, and for analyzing laboratory experiment results;
monitoring of
scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices;
remote scientific testing services of chemicals, pharmaceuticals,
biologics, vaccines, and medical devices;
biopharmaceutical research and scientific testing services;
biopharmaceutical
research design and scientific testing services;
monitoring product safety and quality assurance testing for pharmaceuticals, biopharmaceuticals, chemicals,
medical devices, vaccines, and biologics;
product safety and quality assurance testing services for pharmaceuticals, biopharmaceuticals, chemicals, medical
devices, vaccines, and biologics;
monitoring toxicological safety testing services for pharmaceuticals, chemicals, and consumer products;
toxicological safety and quality assurance testing services for pharmaceuticals, chemicals, and consumer products;
software as a
service for developing, executing, monitoring, and managing enterprise resource planning, experimental logistics, manufacturing execution systems, and connected factories;
software as a service featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical
phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment
results;
software as a service for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following
experiments, and for performing internal audits following experiments;
software as a service for processing of un-structured, semi-structured, and
structured information relating to laboratory experiments and computer simulations of laboratory experiments and biological and chemical phenomena and systems.Class 042 for Medical
laboratory services; scientific laboratory services; conducting laboratory experiments remotely; software as a service featuring software for designing laboratory experiments, for running laboratory
experiments, for analyzing laboratory experiment controls, equipment, and environment data, and for analyzing laboratory experiment results; remote scientific testing services of chemicals,
pharmaceuticals, biologics, vaccines, and medical devices; biopharmaceutical research design and scientific testing services; product safety and quality assurance testing services for
pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; toxicological safety and quality assurance testing services for pharmaceuticals, chemicals, and consumer
products; software as a service for developing, executing, monitoring, and managing enterprise resource planning, experimental logistics, manufacturing execution systems, and connected
factories; software as a service featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena
and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results;
software as a service for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits
following experiments; software as a service for processing of un-structured, semi-structured, and structured information relating to laboratory experiments and computer simulations of
laboratory experiments and biological and chemical phenomena and systems.
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with
the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 07/19/2017 and first used in commerce at least as early as 07/19/2017 , and
is now in use in such commerce.
The applicant's current attorney information: Paul K. Tomita. Paul K. Tomita of STANIFORD TOMITA LLP, is located at
PO BOX 591838
SAN FRANCISCO, California 94159
US
The docket/reference number is ECL.14.
The phone number is 415-305-8948.
The email address is paul@st-ip.com
The applicants proposed attorney information: Paul K. Tomita. Paul K. Tomita of STANIFORD TOMITA LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located
at
PO BOX 591838
SAN FRANCISCO, California 94159
United States
The docket/reference number is ECL.14.
The phone number is 415-305-8948.
The email address is paul@st-ip.com
Paul K. Tomita submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current correspondence information: PAUL K. TOMITA. PAUL K. TOMITA of STANIFORD TOMITA LLP, is located at
PO BOX 591838
SAN FRANCISCO, California 94159
US
The docket/reference number is ECL.14.
The phone number is 415-305-8948.
The email address is paul@st-ip.com; ptomita@gmail.com; lana@st-ip.com
The applicants proposed correspondence information: Paul K. Tomita. Paul K. Tomita of STANIFORD TOMITA LLP, is located at
PO BOX 591838
SAN FRANCISCO, California 94159
United States
The docket/reference number is ECL.14.
The phone number is 415-305-8948.
The email address is paul@st-ip.com; ptomita@gmail.com; lana@st-ip.com
SIGNATURE(S)
Response Signature
Signature: /Paul K. Tomita/ Date: 10/29/2019
Signatory's Name: Paul K. Tomita
Signatory's Position: Attorney of Record, CA bar member
Signatory's Phone Number: 4153058948
The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and
any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another
U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed
revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter;
or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.
Mailing Address: PAUL K. TOMITA
STANIFORD TOMITA LLP
PO BOX 591838
SAN FRANCISCO, California 94159
Mailing Address: Paul K. Tomita
STANIFORD TOMITA LLP
PO BOX 591838
SAN FRANCISCO, California 94159
Serial Number: 88291857
Internet Transmission Date: Tue Oct 29 23:19:51 EDT 2019
TEAS Stamp: USPTO/ROA-XXX.X.XXX.XX-20191029231951363
174-88291857-700e21b307f345af65ea471d891
86e989a6beeccb51b46fdc850c2e385abb9f34e-
N/A-N/A-20191029231536293653